Biologics Help Wyeth, Schering Blunt The Pain Of Tough U.S. Market

Strong sales of biologics and global diversification buttressed both Wyeth and Schering-Plough - at least partially - against a tough U.S. operating environment in the third quarter and first nine months of 2008